{"nct_id":"NCT02310763","title":"A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy","status":"TERMINATED","status_verified_date":"2020-10","start_date":"2014-11-24","start_date_type":"ACTUAL","primary_completion_date":"2018-04-30","primary_completion_date_type":"ACTUAL","completion_date":"2018-11-23","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PFE"]}